Dr. Jef Pinxteren oversees the process and analytical development for Catalent’s Cell Therapy business in Europe. Prior to Catalent, he has headed R&D, Process Development and Operational functions across innovative companies such as Promethera Biosciences and Athersys/ReGenesys. His industry experience is complemented with a solid academic background in progressing research across many cell types. With over 30 years of experience, Jef holds a Ph.D. in Biochemistry from the University of Antwerp and has worked with an EMBO fellowship at University College London. He has also spent time at University of Alabama Birmingham and University of North Carolina in the US. During his professional tenure, he has been managing academic-industrial partnerships across US, Europe and Australia.